about
Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developmentsStructural Mechanism of Ring-opening Reaction of Glucose by Human Serum AlbuminStudies of metabolite-protein interactions: a reviewComparison of modification sites formed on human serum albumin at various stages of glycationDetermination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction.Research in bioanalysis and separations at the University of Nebraska - Lincoln.Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography.Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albuminStudies of drug interactions with glycated human serum albumin by high-performance affinity chromatography.Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albuminAnalysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albuminUse of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.Review: Glycation of human serum albumin.CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME.Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin.Analysis of biomolecular interactions using affinity microcolumns: a review.Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.Role of the flavan-3-ol and galloyl moieties in the interaction of (-)-epigallocatechin gallate with serum albumin.Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albuminRevealing binding interaction between seven drugs and immobilized β2-adrenoceptor by high-performance affinity chromatography using frontal analysis.An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.Effect of Temperature on Tolbutamide Binding to Glycated Serum Albumin.Study on the interactions of sulfonylurea antidiabetic drugs with normal and glycated human serum albumin by capillary electrophoresis-frontal analysis.In Vitro Investigation of the Interaction of Tolbutamide and Losartan with Human Serum Albumin in Hyperglycemia States.Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns
P2860
Q27014989-9E19D2D1-7C0C-4846-9B3E-40C8EC3FB564Q27677418-5D449752-0FAF-4FB0-A8D8-B156387C53E9Q33657421-E792B7E8-CBBC-4B7B-9C16-45EF619A9BBEQ33733746-35EB3AD1-688E-4830-8F9C-B0BBF3C97788Q33847684-FC536579-F529-4324-AC15-8A71338F05EDQ33902643-0078E2C5-AF96-4F41-A518-9C20B6711EB9Q33907748-A134F6CA-BFE6-4DCF-8BCA-6F57A53B192FQ34625180-B1ABB27E-EB82-481B-A18D-4013FAA4020AQ35184764-DC54F43A-6C18-4250-B18C-59BF5AE63C66Q35215569-BC3996CD-3A58-480B-91F0-7507F39B8207Q35490770-E4325160-53DA-4873-830D-E2C604A6EA99Q36216660-89B04A61-7AB1-4F13-A5EB-E5652BF12FDEQ36371289-5B3ECA8E-E168-4A85-A38E-621BD138B6FEQ36619568-9DB5DCAC-D280-4738-BC8A-5E5A76AEC4CFQ36966255-B1D75052-5813-4F07-AE66-4A02EDE77831Q36966324-CD3BF1BD-59D1-448F-9E94-98855BB8D0DCQ37227387-D690A80E-E336-40E5-BA92-F22B530A0D09Q37287840-E8A46662-8468-492F-8036-4C6C51AA0D5CQ37385881-8DCEAEA0-D361-4481-AE7C-55D2BA0588BEQ38191351-55F7C074-1A1C-4991-B5D7-E982D2C81E54Q38962729-346B8708-EB6F-4A75-8863-E433D872F890Q39234928-C18B72A7-A79B-4D62-B901-05F7A9E30507Q41831692-DC17A14C-3641-4CF3-9C8E-CA9871921A76Q46582893-044A7461-5075-40FE-9694-3DEEA641EE7CQ47947254-B7030708-81F3-4F7F-8C80-F8240FCECB99Q51079849-100E201E-AC48-4EAA-9E69-4C9BDF3C7DFCQ51622193-BC62B2D0-9824-4D48-877A-FA306EB4CD50Q51776826-7AF39D6E-9047-443F-8031-DD6C5CA14FB3Q52365560-B5FD107B-3263-4351-9DF1-AB18773CC325Q54917687-6CDDFA0A-E989-4890-BA4A-B8871D1A8F3BQ57464227-27F8FABF-7A55-44B3-813B-E38716AB13A5
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Binding of tolbutamide to glycated human serum albumin
@ast
Binding of tolbutamide to glycated human serum albumin
@en
Binding of tolbutamide to glycated human serum albumin
@nl
type
label
Binding of tolbutamide to glycated human serum albumin
@ast
Binding of tolbutamide to glycated human serum albumin
@en
Binding of tolbutamide to glycated human serum albumin
@nl
prefLabel
Binding of tolbutamide to glycated human serum albumin
@ast
Binding of tolbutamide to glycated human serum albumin
@en
Binding of tolbutamide to glycated human serum albumin
@nl
P2093
P2860
P1476
Binding of tolbutamide to glycated human serum albumin
@en
P2093
David S Hage
Jeanethe Anguizola
K S Joseph
P2860
P304
P356
10.1016/J.JPBA.2010.09.003
P577
2010-09-15T00:00:00Z